AlzChem

DYHARD® Conference

25 members of the global DYHARD® Community from the U.S., Asia and Europe attended the 2nd DYHARD® World Sales Conference (DWSC) in Grassau close to Lake Chiemsee.

After presenting the respective local markets, the latest developments of the DYHARD® product portfolio were discussed: innovative technologies such as our DYHARD® fluid epoxy system for filament winding of composite pressure vessels, i.e. for hydrogen mobility. Our objective: TOGETHER FOR ONE VISION.

Creapure® – Creatine monohydrate of the highest quality and purity from Bavaria

For many years, the AlzChem Group has been producing creatine monohydrate under the brand name Creapure® in the heart of Bavaria, the Chiemgau region. Both professional and recreational athletes from all over the world rely on the purity and effectiveness of Creapure®. But what do we need creatine for? And why does it come from Trostberg?

 

ESPN Conference 2019

The 22nd European Symposium on Poultry Nutrition (ESPN) will take place from 10 to 13 June 2019 in Gdansk (Poland).
A great conference, excellent speakers and great discussions are waiting for you. AlzChem will present recent findings on Creamino in turkey nutrition on Thursday, June 13.

We look forward to your visit!

English

AlzChem plans REACH registration for Triethylsilane until September 2019

Triethylsilane is a selective reducing and silylating agent in organic synthesis and is produced by Grignard reaction. AlzChem has been manufacturing this product in Trostberg, Bavaria for more than 10 years and can draw on its wealth of production experience.

MADE IN GERMANY means for us excellent quality and process safety, which makes our Triethylsilane a highly reliable product for the pharmaceutical industry.

 

Andreas Niedermaier becomes new CEO – Dr. Georg Weichselbaumer appointed to the Management Board effective July 1, 2019

Trostberg, June 3, 2019 – The Supervisory Board of AlzChem Group AG has decided to appoint Mr. Andreas Niedermaier (CFO) as the new CEO with effect from July 1, 2019, in view of the resignation of the current CEO Mr. Ulli Seibel as of December 31, 2019. In this function, Mr. Niedermaier will also be responsible for Investor Relations and Communications. Dr. Georg Weichselbaumer was newly appointed to the Management Board effective July 1, 2019. Dr.